This inventor holds 2 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Edward C. Shinal: Innovator in Emulsion Compositions
Introduction
Edward C. Shinal is a notable inventor based in Old Tappan, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of emulsion compositions for drug administration. With a total of 2 patents, his work has focused on enhancing drug absorption and therapeutic efficacy.
Latest Patents
Shinal's latest patents include innovative formulations aimed at improving the administration of sparingly water-soluble drugs. One of his patents describes lipid emulsion compositions designed to eliminate adverse injection site reactions associated with intravenous administration. This formulation enhances drug absorption and therapeutic efficacy for various routes of administration, including oral and intraarticular. Another patent focuses on quick-breaking fat emulsion compositions for parenteral administration, incorporating materials such as benzyl alcohol and various surfactants and oils to optimize drug delivery.
Career Highlights
Edward C. Shinal has had a distinguished career at American Cyanamid Company, where he has been instrumental in advancing drug formulation technologies. His expertise in emulsion compositions has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Shinal has collaborated with notable colleagues, including Eugene A. Carpentier and Madurai G. Ganesan. These collaborations have contributed to the development of innovative solutions in drug administration.
Conclusion
Edward C. Shinal's contributions to emulsion compositions have significantly impacted the pharmaceutical field. His innovative patents continue to enhance drug delivery methods, improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile